Edward N. Rampersaud Jr., MD



email this

Assistant Professor of Surgery
Director of Medical Student Education in Urology
Department / Division:
Surgery / Urology
DUMC 2812
Durham, NC 27710
Appointment Telephone:
Office Telephone:
  • MD, Duke University School of Medicine, 2004
  • Internship, General Surgery, Duke University Medical Center, 2004-2005
  • General Surgery, Duke University Medical Center, 2005-2006
  • Urologic Surgery, Duke University Medical Center, 2007-2009 (Chief Resident, 2009-2010)
  • Urologic Surgery Research, Duke University Medical Center, 2006-2007
  • SUO Urologic Oncology, Institute of Urologic Oncology, University of California–Los Angeles (UCLA), 2010-2012
Clinical Interests:
Kidney cancer (including all facets of care for both localized and advanced pathology: minimally invasive techniques, renal-preservation surgeries, and advanced vascular/caval reconstruction as needed); testicular cancer (including the advanced upper-retroperitoneal and vascular techniques required to address post-chemotherapy pathology); bladder cancer (including bladder-sparing protocols, creation of neobladders, and robotic/minimally invasive techniques); prostate cancer (including robotic prostatectomy and multimodal management of locally advanced pathology); penile cancer (including penile-sparing techniques); advanced genitourinary cancer surgery; diagnosis and treatment of rare/unusual genitourinary and retroperitoneal tumors
Research Interests:
Surgeon clinically focused on the upper retroperitoneum - especially those surgeries involving advanced vascular technique required for kidney cancer operations.
Representative Publications:
  • Klatte, T; Kroeger, N; Rampersaud, EN; Birkhäuser, FD; Logan, JE; Sonn, G; Riss, J; Rao, PN; Kabbinavar, FF; Belldegrun, AS; Pantuck, AJ. Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma. Cancer. 2012;118:5777-5782.  Abstract
  • Kroeger, N; Klatte, T; Birkhäuser, FD; Rampersaud, EN; Seligson, DB; Zomorodian, N; Kabbinavar, FF; Belldegrun, AS; Pantuck, AJ. Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival. Cancer. 2012;118:1795-1802.  Abstract
  • Kroeger, N; Rampersaud, EN; Patard, JJ; Klatte, T; Birkhäuser, FD; Shariat, SF; Lang, H; Rioux-Leclerq, N; Remzi, M; Zomorodian, N; Kabbinavar, FF; Belldegrun, AS; Pantuck, AJ. Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. The Journal of Urology. 2012;187:418-423.  Abstract
  • Kroeger, N; Seligson, DB; Klatte, T; Rampersaud, EN; Birkhäuser, FD; Rao, PN; Leppert, JT; Zomorodian, N; Kabbinavar, FF; Belldegrun, AS; Pantuck, AJ. Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. European Urology. 2012;61:888-895.  Abstract
  • Rampersaud, EN; Belldegrun, AS. Words of Wisdom. Re: randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance. European Urology. 2011;59:301-302.  Abstract
  • Rampersaud, EN; Vujaskovic, Z; Inman, BA. Hyperthermia as a treatment for bladder cancer. Oncology. 2010;24:1149-1155.  Abstract
  • Rampersaud, EN; Sun, L; Moul, JW; Madden, J; Freedland, SJ. Percent tumor involvement and risk of biochemical progression after radical prostatectomy. The Journal of Urology. 2008;180:571-576.  Abstract